Clinical Trials Browser

Phase 2 × OTHER × Neoplasms × Clear all

NCT03089554 2026-05-27

Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

Phase 2 Recruiting

Neoplasms

NCT04181463 2026-05-27

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Phase 2 Not yet recruiting

Neoplasms

NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

NCT02479698 2026-05-20

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Phase 2 Recruiting

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

NCT07205731 2026-05-20

SAFE ESO

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasms

NCT04984733 2026-05-18

ELEVATE

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT06788938 2026-05-18

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

Phase 2 Recruiting

Neoplasms

NCT02693535 2026-05-15

TAPUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT05656651 2026-05-15

ACTIVE

Phase 2 Active not recruiting

Neoplasms

NCT05879146 2026-05-15

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

Phase 2 Recruiting

Neoplasms

NCT00510640 2026-05-14

THYSU

Phase 2 Completed

Neoplasms, Thyroid Neoplasms

NCT00906893 2026-05-14

MISOGLIO

Phase 2 Completed

Hypoxia, Glioblastoma, Neoplasms

NCT04263480 2026-05-12

CZAR-1

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia, Neoplasms

NCT07149207 2026-05-12

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Phase 2 Recruiting

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04266275 2026-05-08

Topical Curcumin for HPV Related Cervical Disease

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Communicable Diseases, Neoplasms

NCT06559228 2026-05-08

ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care

Phase 2 Active not recruiting

Neoplasms

NCT06129747 2026-05-07

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Phase 2 Recruiting

Breast Neoplasms, Neoplasms

NCT01042379 2026-05-06

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT01920932 2026-05-06

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

Phase 2 Active not recruiting

77 enrolled 20 charts

Hodgkin Disease, Neoplasms

NCT03322865 2026-05-06

Obinutuzumab in Marginal Zone Lymphoma

Phase 2 Active not recruiting

Neoplasms, Lymphoma, B-Cell, Marginal Zone

NCT03349450 2026-05-06

SPiReL

Phase 2 Completed

25 enrolled 18 charts

LymphoidSarcoma

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT03474744 2026-05-06

Copanlisib and Rituximab in Marginal Zone Lymphoma Patients

Phase 2 Active not recruiting

Neoplasms, Lymphoma, B-Cell, Marginal Zone

NCT05852717 2026-05-06

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Phase 2 Recruiting

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05947383 2026-05-06

2Dose

Phase 2 Active not recruiting

Depression, Depressive Disorder, Major, Neoplasms

NCT06804655 2026-05-06

EViDENCE-BT

Phase 2 Not yet recruiting

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT05099471 2026-05-05

VIWA-1

Phase 2 Recruiting

Lymphoma, Waldenstrom Macroglobulinemia, Neoplasms

NCT06936748 2026-05-05

SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors

Phase 2 Recruiting

Neoplasms

NCT07354919 2026-05-05

AxeCan

Phase 2 Recruiting

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT03752333 2026-05-04

CUPem

Phase 2 Completed

35 enrolled 11 charts

Carcinoma, Neoplasms, Neoplasms, Unknown Primary

NCT05584826 2026-05-04

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Phase 2 Recruiting

Adjustment Disorders, Neoplasms

NCT05660954 2026-05-04

CABOTHYROID

Phase 2 Completed

Neoplasms, Thyroid Diseases

NCT06416007 2026-05-04

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasms

NCT06417190 2026-05-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Phase 2 Recruiting

Neoplasms

NCT02700386 2026-04-30

Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes

Phase 2 Completed

108 enrolled 14 charts

Breast Neoplasms, Neoplasms

NCT07041788 2026-04-30

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

Phase 2 Not yet recruiting

Neoplasms

NCT03310879 2026-04-29

Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

Phase 2 Recruiting

Neoplasms

NCT06846346 2026-04-28

GRACIE

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT07346677 2026-04-28

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

Phase 2 Not yet recruiting

Neoplasms, Phlebitis

NCT04733534 2026-04-24

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Phase 2 Active not recruiting

Frailty, Neoplasms

NCT04752137 2026-04-24

Intraoperative Tumor Margin Identification With ICG Dye Imaging

Phase 2 Recruiting

Neoplasms

NCT05152472 2026-04-24

ATEZOGIST

Phase 2 Recruiting

GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT03755804 2026-04-23

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Phase 2 Active not recruiting

Hodgkin Disease, Neoplasms

NCT06475352 2026-04-23

FUDOSE

Phase 2 Recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

NCT04095208 2026-04-21

CONGRATS

Phase 2 Completed

Tertiary Lymphoid Structures, Neoplasm Metastasis, Neoplasms, Sarcoma

NCT06623656 2026-04-21

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Phase 2 Recruiting

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Phase 2 Enrolling by invitation

Glioma, Neoplasms, Parkinsonian Disorders

NCT05064280 2026-04-16

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Phase 2 Recruiting

Brain Neoplasms, Neoplasms

NCT06510699 2026-04-16

PRAGMATIC

Phase 2 Recruiting

Other hematologic neoplasm

Communicable Diseases, Infections, Mycoses, Neoplasms, Hematologic Neoplasms